67, 4 biological variation, individual people, and I think you have to watch these and to see what percentage af these people develop tumors as compared to a controlled group. DR. BUGHER: Yes, that will be done. Do you have any feeling yourself for the probabilities involved here in this group? Would you expect any bone sarcoma to be encountered inthis Rongelap group? We have 84 people, is it not? DR. BOND: LT, LOONEY: 10 Alderson Reporting Company Washington, D. C. 82. I would certainly like to have a 11 chance to go over this data much more than I have at the 12 present time before I would 13 on this. 14 permissible level, 15 to see if there is an increase in incident of neoplasia in 16 this people. 17 of these various elements. 18 your bone tumors are the most likely thing to occur. 19 would not want to hazard a guess. 20 21 stick my neck out so to speak But I do think that certainly with this close I don't know too much about the distribution MR. COHN: brought out, that these people are extremely important Most of it is bone. Chances are I There is one point that has not been and that I think should bestressed, is that strontium 89 has a considerably shorter half life than radium 23 ARC but there are a number of short life fission products that would have had to be present in high concentrations for an early interval which we don't pick up after 30 days. The LS